Correlation Between Telomir Pharmaceuticals, and Hudson Technologies

Can any of the company-specific risk be diversified away by investing in both Telomir Pharmaceuticals, and Hudson Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telomir Pharmaceuticals, and Hudson Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telomir Pharmaceuticals, Common and Hudson Technologies, you can compare the effects of market volatilities on Telomir Pharmaceuticals, and Hudson Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telomir Pharmaceuticals, with a short position of Hudson Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telomir Pharmaceuticals, and Hudson Technologies.

Diversification Opportunities for Telomir Pharmaceuticals, and Hudson Technologies

-0.07

Correlation Coefficient

Telomir Pharmaceuticals,  Hudson Technologies

Good diversification

The 3 months correlation between Telomir and Hudson is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Telomir Pharmaceuticals, Commo and Hudson Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hudson Technologies and Telomir Pharmaceuticals, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telomir Pharmaceuticals, Common are associated (or correlated) with Hudson Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hudson Technologies has no effect on the direction of Telomir Pharmaceuticals, i.e., Telomir Pharmaceuticals, and Hudson Technologies go up and down completely randomly.

Pair Corralation between Telomir Pharmaceuticals, and Hudson Technologies

Given the investment horizon of 90 days Telomir Pharmaceuticals, Common is expected to generate 3.32 times more return on investment than Hudson Technologies. However, Telomir Pharmaceuticals, is 3.32 times more volatile than Hudson Technologies. It trades about 0.02 of its potential returns per unit of risk. Hudson Technologies is currently generating about -0.01 per unit of risk. If you would invest  700.00  in Telomir Pharmaceuticals, Common on December 2, 2024 and sell it today you would lose (300.00) from holding Telomir Pharmaceuticals, Common or give up 42.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	53.94%
Values	Daily Returns

Telomir Pharmaceuticals, Commo  vs.  Hudson Technologies

Telomir Pharmaceuticals,

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Telomir Pharmaceuticals, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating essential indicators, Telomir Pharmaceuticals, may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Hudson Technologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Hudson Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Hudson Technologies is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Telomir Pharmaceuticals, and Hudson Technologies

The main advantage of trading using opposite Telomir Pharmaceuticals, and Hudson Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telomir Pharmaceuticals, position performs unexpectedly, Hudson Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hudson Technologies will offset losses from the drop in Hudson Technologies' long position.

The idea behind Telomir Pharmaceuticals, Common and Hudson Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.